Daniel Lorber

5.1k total citations
24 papers, 792 citations indexed

About

Daniel Lorber is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Daniel Lorber has authored 24 papers receiving a total of 792 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Endocrinology, Diabetes and Metabolism, 4 papers in Surgery and 3 papers in Molecular Biology. Recurrent topics in Daniel Lorber's work include Diabetes Management and Research (5 papers), Diabetes Treatment and Management (5 papers) and Pharmacology and Obesity Treatment (3 papers). Daniel Lorber is often cited by papers focused on Diabetes Management and Research (5 papers), Diabetes Treatment and Management (5 papers) and Pharmacology and Obesity Treatment (3 papers). Daniel Lorber collaborates with scholars based in United States, Netherlands and Ireland. Daniel Lorber's co-authors include Walter T. Kaltenborn, B BURROWS, David Rabin, Anders Boss, Richard Petrucci, T. J. McKenna, André Lacroix, Ann Danoff, Norman Fleischer and L. Clifford McKee and has published in prestigious journals such as New England Journal of Medicine, Diabetes Care and Diabetes.

In The Last Decade

Daniel Lorber

24 papers receiving 749 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Lorber United States 14 411 161 128 124 116 24 792
J. C. Smith United Kingdom 15 434 1.1× 120 0.7× 168 1.3× 296 2.4× 212 1.8× 29 1.0k
B. O. Boehm Germany 13 353 0.9× 129 0.8× 104 0.8× 86 0.7× 154 1.3× 28 795
Marino Bruseghin Italy 10 275 0.7× 88 0.5× 102 0.8× 61 0.5× 112 1.0× 15 754
Ugo Oliviero Italy 16 413 1.0× 139 0.9× 122 1.0× 121 1.0× 331 2.9× 45 827
Ling Ge United States 11 483 1.2× 110 0.7× 192 1.5× 93 0.8× 190 1.6× 24 798
Canan Ersoy Türkiye 16 315 0.8× 178 1.1× 120 0.9× 45 0.4× 65 0.6× 90 768
Hasan Altunbaş Türkiye 20 525 1.3× 349 2.2× 201 1.6× 59 0.5× 109 0.9× 49 1.1k
Min Sun China 17 266 0.6× 152 0.9× 178 1.4× 57 0.5× 140 1.2× 68 844
A.D. Rao United States 15 343 0.8× 235 1.5× 168 1.3× 43 0.3× 169 1.5× 30 848
Anne Sofie Astrup Denmark 14 276 0.7× 220 1.4× 121 0.9× 50 0.4× 333 2.9× 20 956

Countries citing papers authored by Daniel Lorber

Since Specialization
Citations

This map shows the geographic impact of Daniel Lorber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Lorber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Lorber more than expected).

Fields of papers citing papers by Daniel Lorber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Lorber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Lorber. The network helps show where Daniel Lorber may publish in the future.

Co-authorship network of co-authors of Daniel Lorber

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Lorber. A scholar is included among the top collaborators of Daniel Lorber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Lorber. Daniel Lorber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shukla, Alpana P., Beverly G. Tchang, Tiffany Lam, et al.. (2021). Preadmission predictors of severe COVID-19 in patients with diabetes mellitus. Journal of Diabetes and its Complications. 35(8). 107967–107967. 6 indexed citations
2.
Lorber, Daniel, et al.. (2019). 1256-P: Assessing Truck Drivers with Diabetes: The Clinician's Role. Diabetes. 68(Supplement_1). 1 indexed citations
3.
Mathieu, Chantal, R. Ravi Shankar, Daniel Lorber, et al.. (2015). A Randomized Clinical Trial to Evaluate the Efficacy and Safety of Co-Administration of Sitagliptin with Intensively Titrated Insulin Glargine. Diabetes Therapy. 6(2). 127–142. 32 indexed citations
4.
Lorber, Daniel. (2014). Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus. Diabetes Metabolic Syndrome and Obesity. 7. 169–169. 142 indexed citations
5.
Lorber, Daniel. (2013). GLP‐1 Receptor Agonists: Effects on Cardiovascular Risk Reduction. Cardiovascular Therapeutics. 31(4). 238–249. 62 indexed citations
6.
Cox, Daniel J., Harsimran Singh, Daniel Lorber, & Kathie L. Hermayer. (2013). Diabetes and Driving Safety: Science, Ethics, Legality and Practice. The American Journal of the Medical Sciences. 345(4). 263–265. 32 indexed citations
7.
Lorber, Daniel. (2012). GLP-1 Receptor Agonists: Effects on Cardiovascular Risk Reduction. Cardiovascular Therapeutics. n/a–n/a. 9 indexed citations
8.
Lorber, Daniel, et al.. (2012). Stopping Diabetes Through Advocacy: The Role of Health Care Professionals. Clinical Diabetes. 30(4). 179–182. 1 indexed citations
9.
Boss, Anders, Richard Petrucci, & Daniel Lorber. (2012). Coverage of Prandial Insulin Requirements by Means of an Ultra-Rapid-Acting Inhaled Insulin. Journal of Diabetes Science and Technology. 6(4). 773–779. 46 indexed citations
10.
Lorber, Daniel & Donal Reddan. (2006). Clinical characteristics of chronic kidney disease patients with and without diabetes: a subanalysis of the PAERI study. Clinical Nephrology. 66(7). 11–16. 14 indexed citations
11.
Brunton, Stephen, et al.. (2005). Type 2 diabetes: the role of insulin.. PubMed. 54(5). 445–52. 12 indexed citations
12.
Lorber, Daniel. (1998). What works? The Diabetes Care and Information Center. Diabetic Medicine. 15(S4). S24–S27. 11 indexed citations
13.
Lorber, Daniel. (1995). Nonketotic hypertonicity in diabetes mellitus. Medical Clinics of North America. 79(1). 39–52. 58 indexed citations
14.
Lorber, Daniel. (1993). Non-Ketotic Hypertonicity in Diabetes. The Endocrinologist. 3(1). 29–38. 4 indexed citations
15.
Tibaldi, Joseph M., et al.. (1992). Postprandial hypoglycemia in islet beta cell hyperplasia with adenomatosis of the pancreas. Journal of Surgical Oncology. 50(1). 53–57. 6 indexed citations
17.
McKee, L. Clifford, et al.. (1983). The Endocrine Manifestations of Hemochromatosis. The American Journal of the Medical Sciences. 285(3). 7–13. 39 indexed citations
18.
McKenna, T. J., Daniel Lorber, André Lacroix, & David Rabin. (1979). TESTICULAR ACTIVITY IN CUSHING'S DISEASE. European Journal of Endocrinology. 91(3). 501–510. 49 indexed citations
19.
Rabinowitz, D., Robert Benveniste, J Lindner, Daniel Lorber, & James Daniell. (1979). Isolated Follicle-Stimulating Hormone Deficiency Revisited. New England Journal of Medicine. 300(3). 126–128. 30 indexed citations
20.
Lorber, Daniel, Marvin J. Tenenbaum, Stephen E. Thurston, G.W. Gander, & F. Goodale. (1971). The Fate of Circulating Leukocytic Pyrogen in the Rabbit1,2. Experimental Biology and Medicine. 137(3). 896–901. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026